BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma & Biopharma Manufacturing

China NMPA Approves MicuRx's Contezolid for Treatment of Drug-Resistant Bacterial Infection

By leveraging the proprietary technology platform built for drug discovery and screening, MicuRx R&D team discovered the next-generation oxazolidinone ...

June 04, 2021 | News

Cytiva acquires GoSilico to to strengthen digital capabilities in bioprocessing

GoSilico's software creates “digital twins” of downstream processes and is increasingly used to enhance process development by simulation Mo...

June 02, 2021 | News

Moderna, Thermo Agreement to leverage manufacturing capacity to continue to drive global supply of vaccines

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has entered i...

June 02, 2021 | News

Avantor Acquires RIM Bio; Expands Bioproduction Footprint into China

Changzhou, China operations become Avantor's first single-use production facility in AMEA region; doubles Avantor's global single-use cleanroom space- Adds...

June 02, 2021 | News

Precision NanoSystems joins Danaher’s Life Sciences Platform

Vancouver, Canada-based Precision NanoSystems (PNI) provides technology solutions enabling the development and manufacturing of lipid nanoparticles fo...

June 01, 2021 | News

Novartis provides update on BEOVU clinical program

Novartis has also decided on early termination of the RAPTOR and RAVEN studies, which assessed the efficacy and safety of brolucizumab in retinal vein occl...

May 30, 2021 | News

Liminal BioSciences Update Clinical Activities for Fezagepras

Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, announced today that bas...

May 31, 2021 | News

Multiply Labs Joins forces with Cytiva to automate cell therapy manufacturing.

Creating a fully automated robotic system will bring industrial scale reliability to cell therapy manufacturing while providing speed and flexibi...

May 26, 2021 | News

Cytiva and Prestige Biopharma to accelerate manufacturing COVID-19 vaccines and antibody therapies.

Cytiva and Prestige Biopharma have formed a collaboration to accelerate manufacturing COVID-19 vaccines and antibody therapies. With Cytiva’s cell cu...

May 26, 2021 | News

The Cost of Under- and Over-Coating Zinc

But for manufacturers who provide these zinc-coated products, the cost of zinc has increased substantially over the past few years, emphasizing the need to...

May 26, 2021 | Opinion | By By Chris Burnett

COVAXIN® production volumes ramped up by Bharat Biotech, by additional 200 million

The company plans to produce 200 million doses of COVAXIN® per annum in the good manufacturing practice (GMP) facilities that are already operatio...

May 21, 2021 | News

Basilea awarded CARB-X grant of up to USD 2.7 million

Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has been awarded a grant of up to USD 2.7 million from CARB-X (Combating Antibiotic-Resistan...

May 19, 2021 | News

BD to Build New €165 Million Manufacturing Facility in Zaragoza, Spain

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will build a €165 million ($200 million USD) h...

May 18, 2021 | News

Cytiva launches sustainability plan - ‘Designing in sustainability’

Cytiva sets out a sustainability plan to positively affect people and the planet, which underpins business resilience in a fast-changing world Performan...

May 13, 2021 | News

Stay Connected